FDA NDC Directory · JSON-LD · Markdown

Adenosine

NDC 23155-258 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202313
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsADENOSINE (3 mg/mL)
Marketing started20210301
Package count4

External sources

Source: openFDA. Public-domain (CC0).